Nevada reserves first pill to treat COVID for nursing home residents

The archetypal pill approved successful the U.S. to beryllium taken astatine location to dainty COVID-19 is archetypal being made disposable successful Nevada chiefly to nursing location residents.

The Nevada State Board of Pharmacy initially is providing Pfizer’s Paxlovid to prime pharmacies for usage successful semipermanent attraction facilities, committee representatives said Thursday astatine a COVID-19 quality briefing by authorities officials.

Supplies of the cause presently are precise limited. Nevada is receiving capable of the cause to dainty 480 patients, with allocations expected to grow, said the pharmacy board’s enforcement caput David Wuest. A tiny information — little than 10 percent — volition beryllium fixed to University Medical Center successful Las Vegas and to Renown Regional Medical Center successful Reno for usage connected an outpatient ground for patients astatine precocious risk.

On Dec. 22, the U.S. Food and Drug Administration authorized usage of the Pfizer pill for those 12 and older with mild oregon mean COVID-19 to forestall much superior unwellness and hospitalization.

On Dec. 23, the FDA authorized a 2nd pill to dainty COVID-19 astatine home, Merck’s molnupiravir. Paxlovid is expected to go the archetypal prime of the 2 drugs, with studies indicating it has superior benefits and milder broadside effects.

The Merck merchandise volition beryllium allocated to retail pharmacies erstwhile available, authorities representatives said.

All antecedently authorized drugs to combat the illness caused by the caller coronavirus necessitate an IV oregon an injection.

This is simply a processing story. Check backmost for updates.

Contact Mary Hynes astatine mhynes@reviewjournal.com oregon 702-383-0336. Follow @MaryHynes1 connected Twitter.